FAM109CRISPRプラスミド
サンタクルスバイオテクノロジー社は遺伝子サイレンシング用のCRISPR/Cas9ノックアウト及びCRISPR Double Nickaseプラスミドを含め、広範囲の遺伝子編集製品を提供しております。FAM109遺伝子サイレンサーは、FAM109 CRISPR/Cas9ノックアウトプラスミドとFAM109Double Nickaseプラスミドとして利用可能です。遺伝子活性化用のFAM109CRISPR/dCas9 Activationプラスミド及びCRISPR Lenti Activationシステムも利用できます。遺伝子サイレンサーと活性化剤はタンパク質の検出に使用された抗体と組み合わせた遺伝子研究に有用です。
FAM109 CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
FAM109A CRISPR/Cas9 KOプラスミド (h) | sc-417438 | h | Gene Knockout | GFP | 0 | ||
FAM109A HDRプラスミド (h) | sc-417438-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
FAM109A Double Nickaseプラスミド (h) | sc-417438-NIC | h | Gene Knockout | Puromycin | 0 | ||
FAM109A Double Nickaseプラスミド (h2) | sc-417438-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
FAM109A CRISPR/Cas9 KOプラスミド (m) | sc-433098 | m | Gene Knockout | GFP | 0 | ||
FAM109A HDRプラスミド (m) | sc-433098-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
FAM109A Double Nickaseプラスミド (m) | sc-433098-NIC | m | Gene Knockout | Puromycin | 0 | ||
FAM109A Double Nickaseプラスミド (m2) | sc-433098-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
FAM109B CRISPR/Cas9 KOプラスミド (h) | sc-414681 | h | Gene Knockout | GFP | 0 | ||
FAM109B HDRプラスミド (h) | sc-414681-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
FAM109B Double Nickaseプラスミド (h) | sc-414681-NIC | h | Gene Knockout | Puromycin | 0 | ||
FAM109B Double Nickaseプラスミド (h2) | sc-414681-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
FAM109B CRISPR/Cas9 KOプラスミド (m) | sc-436116 | m | Gene Knockout | GFP | 0 | ||
FAM109B HDRプラスミド (m) | sc-436116-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
FAM109B Double Nickaseプラスミド (m) | sc-436116-NIC | m | Gene Knockout | Puromycin | 0 | ||
FAM109B Double Nickaseプラスミド (m2) | sc-436116-NIC-2 | m | Gene Knockout | Puromycin | 0 |
FAM109 CRISPR Activation Products
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
FAM109A CRISPR Activationプラスミド (h) | sc-417438-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
FAM109A CRISPR Activationプラスミド (h2) | sc-417438-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
FAM109A Lentiviral Activation Particles (h) | sc-417438-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
FAM109A Lentiviral Activation Particles (h2) | sc-417438-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
FAM109A CRISPR Activationプラスミド (m) | sc-433098-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
FAM109A CRISPR Activationプラスミド (m2) | sc-433098-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
FAM109A Lentiviral Activation Particles (m) | sc-433098-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
FAM109A Lentiviral Activation Particles (m2) | sc-433098-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
FAM109B CRISPR Activationプラスミド (h) | sc-414681-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
FAM109B CRISPR Activationプラスミド (h2) | sc-414681-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
FAM109B Lentiviral Activation Particles (h) | sc-414681-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
FAM109B Lentiviral Activation Particles (h2) | sc-414681-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
FAM109B CRISPR Activationプラスミド (m) | sc-436116-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
FAM109B CRISPR Activationプラスミド (m2) | sc-436116-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
FAM109B Lentiviral Activation Particles (m) | sc-436116-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
FAM109B Lentiviral Activation Particles (m2) | sc-436116-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |